Monitor for any takedown announcements under the shelf or ATM. The company's cash burn and development stage make future offerings likely, and any pricing update will signal near-term dilution magnitude.
PROK drugs
PROK drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $1.15entry
- T+1 · 4d ago −9.13%α −8.77% · $1.05
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ProKidney Corp.'s universal shelf registration (File No. 333-299700) became effective on November 10, 2026. This allows the company to sell up to $650 million in securities, including a $200 million ATM equity facility, creating potential dilution overhang for a pre-revenue biotech with no approved products.
Key Facts
- Effectiveness date: November 10, 2026
- Shelf registration file number: 333-299700
- Up to $650 million in securities registered, including $200 million ATM facility
- Company has no approved products and no revenue
- Net tangible book value of $222.8 million as of June 30, 2026
- ATM could increase share count by up to 63% at $1.52 per share
Financial Impact
Up to $650 million in potential dilution; ATM alone could add 63% to share count at current price
Risk Factors
- Significant dilution risk from potential ATM or shelf takedowns
- No approved products or revenue to offset dilution
- Pre-revenue biotech with uncertain clinical and regulatory timeline
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003506 |
| Document: 9999999995-26-003506-index.html | 9999999995-26-003506 |
| Document: 9999999995-26-003506.txt | 9999999995-26-003506 |
Track record
13 reports on PROK
4 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.51% at T+1 after the Oct 29, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Bearish 7/10 Entry $1.05 to $1.04 Now $1.04 +0.48% ▲ +0.48% −1.43% vs SPY
- Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $1.15 to $1.05 Now $1.04 +9.57% ▲ +9.13% +8.77% vs SPY
- Nov 12, 20265d ago EFFECT Bearish 5/10 Viewing Entry $1.15 to $1.05 Now $1.04 +9.57% ▲ +9.13% +8.77% vs SPY
- Nov 9, 20267d ago 8-K Neutral 3/10 Entry $1.15 to $1.11 Now $1.04 −9.57% ▼ −3.48% −3.11% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $1.30 to $1.12 Now $1.04 +19.69% ▲ +13.51% +13.03% vs SPY
- Oct 29, 202618d ago S-3 Bearish 6/10 Entry $1.30 to $1.12 Now $1.04 +19.69% ▲ +13.51% +13.03% vs SPY
- Oct 22, 202625d ago Press Release Neutral 3/10 Entry $1.43 to $1.41 Now $1.04 −27.27% ▼ −1.40% −0.88% vs SPY
- Aug 10, 202614w ago 8-K Neutral 5/10 No price data
- Aug 10, 202614w ago Press Release Neutral 5/10 Entry $1.61 to $1.48 Now $1.04 −35.40% ▼ −8.07% −8.32% vs SPY
- May 15, 202626w ago 8-K Neutral 4/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers